Board Meeting Details

  • Meeting Date: Thursday, 5th November, 2026
  • Meeting Location: Registered Office of the Company
  • Primary Agenda: Consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2026
  • The document specifies "inter-alia" indicating there may be additional agenda items

Filing Details

  • Reference Number: SFIL/COSEC/BSE/Q3/BM5/2910/2026-27
  • Submission Date: Thursday, 29th October, 2026
  • Digital signature timestamp: 2026.10.29 14:49:30 +0530 and 2026.10.29 14:50:05 +05'30'

Financial Impact

Financial impact not quantified in this disclosure. The meeting is scheduled to review and approve financial results for Q2 FY27 (quarter ended September 30, 2026).